3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
8
Leukemia
6
Leukemia, Myeloid, Acute
5
Myelodysplastic Syndromes
3
Lung Neoplasms
3
Congenital Abnormalities
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Monoclonal Gammopathy of Undetermined Significance
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Colonic Neoplasms
2
Central Nervous System Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
atezolizumab
5
durvalumab
4
Drug Therapy
4
Carboplatin
4
Psychiatric Rehabilitation
3
Immunotherapy
3
Topotecan
2
Specimen Handling
2
Radiotherapy
2
Polymerase Chain Reaction
2
PM 01183
2
Observation
2
Mental Status and Dementia Tests
2
Magnetic Resonance Spectroscopy
2
Immunohistochemistry
2
Immune Checkpoint Inhibitors
2
Ifosfamide
2
Etoposide
2
Cisplatin
2
Biopsy
2
trastuzumab deruxtecan
1
nedaplatin
1
X-Ray Therapy
1
Watchful Waiting
1
Vinorelbine
1
Tomography, Optical Coherence
1
Tissue Banks
1
Therapeutics
1
Radiation, Ionizing
1
Phlebotomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Small Cell Lung Carcinoma
×
In Situ Hybridization, Fluorescence
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled